Are gadolinium-based contrast media nephrotoxic? A renal biopsy study

Archives of Pathology and Laboratory Medicine

Volumn 130, Issue 9, 2006, Pages 1354-1357

  Akgun, Hulya ^a,b   Gonlusen, Gulfiliz ^a,b   Cartwright Jr , Joiner ^b   Suki, Wadi N ^c   Truong, Luan D ^a  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c Kidney Institute of Houston   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; GADODIAMIDE; GADOLINIUM PENTETATE; HYDROCHLOROTHIAZIDE; VALSARTAN;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; CASE REPORT; CELL ULTRASTRUCTURE; CLINICAL FEATURE; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; EDEMA; FEMALE; GLOMERULUS BASEMENT MEMBRANE; HEADACHE; HUMAN; HUMAN TISSUE; HYPERTENSIVE CRISIS; IMAGE ENHANCEMENT; KIDNEY BIOPSY; KIDNEY FUNCTION; KIDNEY INTERSTITIUM; KIDNEY TUBULE DAMAGE; MENINGIOMA; MESANGIUM CELL; NEPHROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; SYMPTOM;

BIOPSY; CONTRAST MEDIA; CREATININE; FEMALE; GADOLINIUM; HUMANS; KIDNEY; KIDNEY NEOPLASMS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; PENTETIC ACID;

EID: 33748552382     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Rieger J, Sitter T, Toepfer M, Linsenmaier U, Pfeifer KJ, Schiffl H. Gadolinium as an alternative contrast agent for diagnostic and interventional angiographic procedures in patients with impaired renal function. Nephrol Dial Transplant. 2002;17:824-828.
2. Solomon R. Contrast-medium-induced acute renal failure. Kidney Int. 1998;53:230-242.
3. Spinosa DJ, Kaufmann JA, Hartwell GD. Gadolinium chelates in angiography and interventional radiology: a useful alternative to iodinated contrast media for angiography. Radiology. 2002;223:319-325, discussion 326-327.
4. Prince MR, Arnoldus C, Frisoli JK. Nephrotoxicity of high-dose gadolinium compared with iodinated contrast. J Magn Reson Imaging. 1996;6:162-166.
5. Spencer A, Wilson S, Harpur E. Gadolinium chloride toxicity in the mouse. Hum Exp Toxicol. 1998;17:633-637.
6. Weinmann HJ, Brasch RC, Press WR, Wesbey GE. Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent. Am J Roentgenol. 1984;142:619-624.
7. Sam AD 2nd, Morasch MD, Collins J, Song G, Chen R, Pereles FS. Safety of gadolinium contrast angiography in patients with chronic renal insufficiency. J Vasc Surg. 2003;38:313-318.
8. Thomsen HS, Morcos SK. Contrast media and the kidney: European Society of Urogenital Radiology (ESUR) guidelines. Br J Radiol. 2003;76:513-518.
9. Sekido T, Sagami F, Tirone P, Morisetti A, Bussi S, Masters RE. General toxicity study of gadobenate dimeglumine formulation (E7155) (2): single dose intravenous toxicity study in dogs [abstract]. J Toxicol Sci. 1999;24(suppl 1):7-18.
10. Gemery J, Idelson B, Reid S, et al. Acute renal failure after arteriography with a gadolinium-based contrast agent. Am J Roentgenol. 1998;171:1277-1278.
11. Schenker MP, Solomon JA, Roberts DA. Gadolinium arteriography complicated by acute pancreatitis and acute renal failure. J Vasc Interv Radiol. 2001;12:393.
12. Nyman U, Elmstahl B, Leander P, Nilsson M, Golman K, Almen T. Are gadolinium-based contrast media really safer than iodinated media for digital subtraction angiography in patients with azotemia? Radiology. 2002;223:311-318.
13. Rosenthal DI, Becerra CR, Toto RD, Carbone DP, Frenkel EP. Reversible renal toxicity resulting from high single doses of the new radiosensitizer gadolinium texaphyrin. Am J Clin Oncol. 2000;23:593-598.
14. Thomsen HS. Guidelines for contrast media from the European Society of Urogenital Radiology. Am J Roentgenol. 2003;181:1463-1471.
15. Murphy SW, Barrett BJ, Parfre PS. Contrast nephropathy. J Am Soc Nephrol. 2000;11:177-182.